Aravindhan S, et al. Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature. Cancer Cell Int. 2021;21(1):158.
Article
PubMed
PubMed Central
CAS
Google Scholar
He N, et al. MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway. Cell Death Dis. 2018;9(10):1026.
Article
PubMed
PubMed Central
Google Scholar
Khakoo AY, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma. J Exp Med. 2006;203(5):1235–47.
Article
PubMed
PubMed Central
CAS
Google Scholar
Suzuki K, et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med. 2011;17(7–8):579–87.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chen J, et al. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma. Cell Death Dis. 2019;10(6):425.
Article
PubMed
PubMed Central
Google Scholar
Lee HY, Hong IS. Double-edged sword of mesenchymal stem cells: cancer-promoting versus therapeutic potential. Cancer Sci. 2017;108(10):1939–46.
Article
PubMed
PubMed Central
CAS
Google Scholar
Niess H, et al. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg. 2011;254(5):767–74 (discussion 774–5).
Article
PubMed
Google Scholar
Lee MW, et al. Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges. Leukemia. 2019;33(3):597–611.
Article
PubMed
PubMed Central
Google Scholar
Niess H, et al. Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial. BMC Cancer. 2015;15:237.
Article
PubMed
PubMed Central
Google Scholar
Portnow J, et al. Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients. Cancer Gene Ther. 2021;28(3–4):294–306.
Article
PubMed
CAS
Google Scholar
Ho YK, et al. A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy. Sci Rep. 2020;10(1):14257.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tu GXE, et al. A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth. Stem Cell Res Ther. 2020;11(1):391.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bahsoun S, Coopman K, Akam EC. The impact of cryopreservation on bone marrow-derived mesenchymal stem cells: a systematic review. J Transl Med. 2019;17(1):397.
Article
PubMed
PubMed Central
Google Scholar
Woods EJ, et al. Off the shelf cellular therapeutics: factors to consider during cryopreservation and storage of human cells for clinical use. Cytotherapy. 2016;18(6):697–711.
Article
PubMed
Google Scholar
Marquez-Curtis LA, et al. Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology. 2015;71(2):181–97.
Article
PubMed
CAS
Google Scholar
Ginis I, Grinblat B, Shirvan MH. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods. 2012;18(6):453–63.
Article
PubMed
CAS
Google Scholar
Antebi B, et al. Cryopreserved mesenchymal stem cells regain functional potency following a 24-h acclimation period. J Transl Med. 2019;17(1):297.
Article
PubMed
PubMed Central
Google Scholar
Yuan Z, et al. Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy. Cytotherapy. 2016;18(7):860–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim TK, Eberwine JH. Mammalian cell transfection: the present and the future. Anal Bioanal Chem. 2010;397(8):3173–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ramos-Murillo AI, et al. Efficient non-viral gene modification of mesenchymal stromal cells from umbilical cord Wharton’s jelly with polyethylenimine. Pharmaceutics. 2020;12(9):896.
Article
PubMed Central
CAS
Google Scholar
Larsen AK, et al. Polyethylenimine-mediated impairment of mitochondrial membrane potential, respiration and membrane integrity: implications for nucleic acid delivery and gene therapy. Mitochondrion. 2012;12(1):162–8.
Article
PubMed
CAS
Google Scholar
Frei T, et al. Characterization and mitigation of gene expression burden in mammalian cells. Nat Commun. 2020;11(1):4641.
Article
PubMed
PubMed Central
CAS
Google Scholar
Salkhordeh M, et al. Effect of cryopreservation of mesenchymal stromal cells after non-viral transfection on cell viability and transgene expression. Cytotherapy. 2020;22:S101.
Article
Google Scholar
Guercio A, et al. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biol Int. 2012;36(2):189–94.
Article
PubMed
CAS
Google Scholar
Ho YK, et al. Enhanced non-viral gene delivery by coordinated endosomal release and inhibition of β-tubulin deactylase. Nucleic Acids Res. 2017;45(6):e38.
Article
PubMed
Google Scholar
He A, et al. Cryopreservation of viable human tissues: renewable resource for viable tissue, cell lines, and organoid development. Biopreserv Biobank. 2020;18(3):222–7.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shafa M, et al. Long-term stability and differentiation potential of cryopreserved cGMP-compliant human induced pluripotent stem cells. Int J Mol Sci. 2019;21(1):108.
Article
PubMed Central
Google Scholar
Pomeroy EJ, et al. A genetically engineered primary human natural killer cell platform for cancer immunotherapy. Mol Ther. 2020;28(1):52–63.
Article
PubMed
CAS
Google Scholar
Shim J, et al. Safety and efficacy of Wharton’s jelly-derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: a phase I/IIa study. Stem Cells Transl Med. 2021;10(4):554–67.
Article
PubMed
CAS
Google Scholar
Lanzoni G, et al. Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS). CellR4 Repair Replace Regen Reprogram. 2020;8:e2839.
PubMed
PubMed Central
Google Scholar
Ostrowska A, et al. Hypothermic storage of isolated human hepatocytes: a comparison between University of Wisconsin solution and a hypothermosol platform. Arch Toxicol. 2009;83(5):493–502.
Article
PubMed
CAS
Google Scholar
Williams LB, et al. Response to intravenous allogeneic equine cord blood-derived mesenchymal stromal cells administered from chilled or frozen state in serum and protein-free media. Front Vet Sci. 2016;3:56.
Article
PubMed
PubMed Central
Google Scholar
Screven R, et al. Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow. Vet Immunol Immunopathol. 2014;161(1–2):21–31.
Article
PubMed
CAS
Google Scholar
Lourenco S, et al. Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors. J Immunol. 2015;194(7):3463–74.
Article
PubMed
CAS
Google Scholar
Zheng XB, et al. Bone marrow-derived CXCR4-overexpressing MSCs display increased homing to intestine and ameliorate colitis-associated tumorigenesis in mice. Gastroenterol Rep (Oxf). 2019;7(2):127–38.
Article
Google Scholar
Dührsen L, et al. Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma. Oncotarget. 2019;10(58):6049–61.
Article
PubMed
PubMed Central
Google Scholar
Rowell JL, McCarthy DO, Alvarez CE. Dog models of naturally occurring cancer. Trends Mol Med. 2011;17(7):380–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Thamm DH. Canine cancer: strategies in experimental therapeutics. Front Oncol. 2019;9:1257.
Article
PubMed
PubMed Central
Google Scholar
Portnow J, et al. Neural stem cell-based anticancer gene therapy: a first-in-human study in recurrent high-grade glioma patients. Clin Cancer Res. 2017;23(12):2951–60.
Article
PubMed
CAS
Google Scholar
Kauer TM, et al. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci. 2011;15(2):197–204.
Article
PubMed
PubMed Central
Google Scholar
Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.
Article
PubMed
CAS
Google Scholar
Cottle C, et al. Impact of cryopreservation and freeze-thawing on therapeutic properties of mesenchymal stromal/stem cells and other common cellular therapeutics. Curr Stem Cell Rep. 2022;8(2):72–92.
Article
PubMed
PubMed Central
CAS
Google Scholar
Moll G, et al. Cryopreserved or Fresh mesenchymal stromal cells: Only a matter of taste or key to unleash the full clinical potential of MSC therapy? Adv Exp Med Biol. 2016;951:77–98.
Article
PubMed
CAS
Google Scholar
Galipeau J. Concerns arising from MSC retrieval from cryostorage and effect on immune suppressive function and pharmaceutical usage in clinical trials. ISBT Sci Ser. 2013;8(1):100–1.
Article
Google Scholar
Galipeau J. The mesenchymal stromal cells dilemma–does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy. 2013;15(1):2–8.
Article
PubMed
Google Scholar
François M, et al. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. Cytotherapy. 2012;14(2):147–52.
Article
PubMed
Google Scholar
Matthay MA, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019;7(2):154–62.
Article
PubMed
Google Scholar
François M, Galipeau J. New insights on translational development of mesenchymal stromal cells for suppressor therapy. J Cell Physiol. 2012;227(11):3535–8.
Article
PubMed
Google Scholar
Moll G, et al. Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells. 2014;32(9):2430–42.
Article
PubMed
CAS
Google Scholar
Chinnadurai R, et al. Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo. Stem Cell Rep. 2014;3(1):60–72.
Article
CAS
Google Scholar
Holubova M, et al. Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment. Biologicals. 2014;42(3):139–44.
Article
PubMed
CAS
Google Scholar
Chin SP, et al. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. Cytotherapy. 2010;12(1):31–7.
Article
PubMed
CAS
Google Scholar
Kotobuki N, et al. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng. 2005;11(5–6):663–73.
Article
PubMed
CAS
Google Scholar
Nguyen MQ, et al. Comparative bioactivity analysis for off-the-shelf and culture-rescued umbilical cord-derived mesenchymal stem/stromal cells in a xeno- and serum-free culture system. Cell Transpl. 2021;30:9636897211039440.
Article
Google Scholar
Linero I, Chaparro O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS ONE. 2014;9(9):e107001.
Article
PubMed
PubMed Central
Google Scholar
Alvites R, et al. Mesenchymal stem/stromal cells and their paracrine activity-immunomodulation mechanisms and how to influence the therapeutic potential. Pharmaceutics. 2022;14(2):381.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhou Y, et al. The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity. J Clin Med. 2019;8(7):1025.
Article
PubMed Central
CAS
Google Scholar
Horiuchi K, et al. Thawed cryopreserved synovial mesenchymal stem cells show comparable effects to cultured cells in the inhibition of osteoarthritis progression in rats. Sci Rep. 2021;11(1):9683.
Article
PubMed
PubMed Central
CAS
Google Scholar
Rogulska O, et al. Novel cryopreservation approach providing off-the-shelf availability of human multipotent mesenchymal stromal cells for clinical applications. Stem Cells Int. 2019;2019:4150690.
Article
PubMed
PubMed Central
Google Scholar
Putra I, et al. Preclinical evaluation of the safety and efficacy of cryopreserved bone marrow mesenchymal stromal cells for corneal repair. Transl Vis Sci Technol. 2021;10(10):3.
Article
PubMed
PubMed Central
Google Scholar
Kenmochi H, et al. Nicotine does not affect stem cell properties requisite for suicide gene therapy against glioma. Neurol Res. 2020;42(10):818–27.
Article
PubMed
CAS
Google Scholar
Menon LG, et al. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells. 2009;27(9):2320–30.
Article
PubMed
CAS
Google Scholar
Sultan F, Ganaie BA. Comparative oncology: Integrating human and veterinary medicine. Open veterinary journal. 2018;8(1):25–34.
Article
PubMed
PubMed Central
Google Scholar
Wang T, et al. Quantitative translation of dog-to-human aging by conserved remodeling of the DNA methylome. Cell Syst. 2020;11(2):176-185.e6.
Article
PubMed
PubMed Central
Google Scholar
Gmeiner WH. Fluoropyrimidine modulation of the anti-tumor immune response-prospects for improved colorectal cancer treatment. Cancers. 2020;12(6):1641.
Article
PubMed Central
CAS
Google Scholar
Tian J, et al. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING. EMBO J. 2021;40(7):e106065.
Article
PubMed
PubMed Central
CAS
Google Scholar
Luu AK, Wood GA, Viloria-Petit AM. Recent advances in the discovery of biomarkers for canine osteosarcoma. Front Vet Sci. 2021;8:734965.
Article
PubMed
PubMed Central
Google Scholar
Walters K, et al. Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients. BMC Vet Res. 2021;17(1):378.
Article
PubMed
PubMed Central
CAS
Google Scholar